Login / Register Submit Your Article
cover
Journal of Public Health & Environment

Volume 3, 2020 - Issue 2

Submit Manuscript Journal Homepage
Latest Issue
Input keywords, title, abstract, author, affiliation etc..
Article Menu
Browse this journal
Vol. 8 (2025)
Vol. 7 (2024)
Vol. 6 (2023)
Vol. 5 (2022)
Vol. 4 (2021)
Vol. 3 (2020)
Vol. 2 (2019)
Vol. 1 (2018)
Updates more >>
1 February 2024 Journal of Public Health & Environment Honors Exceptional Reviewers with 2023 Best Reviewer Awards
1 June 2023 Statement on Supporting the Use of GPT Models in Research
1 March 2023 Journal of Public Health & Environment Honors Distinguished Reviewer of 2022
31 January 2022 Best Reviewer Award for 2021
5 February 2020 Call for Papers: Special Issue 2020
Cooperative Partner

 

  

Journal Article An open access journal
Journal Article

Cancer Research and Therapies: Cutting-edge Approaches to Diagnosis and Treatment

by Dylan Gonzales 1,*
1
Universiti Utara Malaysia
*
Author to whom correspondence should be addressed.
JPHE  2020 3(2):47; https://doi.org/10.xxxx/xxxxxx
Received: 7 August 2020 / Accepted: 5 September 2020 / Published Online: 13 November 2020
View Full-Text
Download PDF

Abstract

Cancer research and therapies have witnessed remarkable advancements in recent years, driven by innovations in molecular biology, genomics, and immunotherapy. This paper provides an overview of cutting-edge approaches to cancer diagnosis and treatment, focusing on precision medicine, targeted therapies, and immunotherapeutic interventions. Key topics include next-generation sequencing technologies for tumor profiling, biomarker discovery for patient stratification, and the development of novel anticancer agents, including small molecules and monoclonal antibodies. Additionally, the paper explores the role of immunotherapy in harnessing the immune system to recognize and eradicate cancer cells, highlighting recent breakthroughs in immune checkpoint inhibitors, chimeric antigen receptor (CAR) T-cell therapy, and cancer vaccines. By synthesizing insights from basic science research and clinical trials, this paper aims to elucidate the promise and challenges of translating scientific discoveries into effective cancer treatments.

Keywords: cancer research; cancer therapies; precision medicine; immunotherapy.;
Copyright: © 2020 by Gonzales. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY) (Creative Commons Attribution 4.0 International License). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

Share and Cite

ACS Style
Gonzales, D. Cancer Research and Therapies: Cutting-edge Approaches to Diagnosis and Treatment. Journal of Public Health & Environment, 2020, 3, 47. doi:10.xxxx/xxxxxx
AMA Style
Gonzales D. Cancer Research and Therapies: Cutting-edge Approaches to Diagnosis and Treatment. Journal of Public Health & Environment; 2020, 3(2):47. doi:10.xxxx/xxxxxx
Chicago/Turabian Style
Gonzales, Dylan 2020. "Cancer Research and Therapies: Cutting-edge Approaches to Diagnosis and Treatment" Journal of Public Health & Environment 3, no.2:47. doi:10.xxxx/xxxxxx

Article Metrics

Article Access Statistics

References

  1. Hanahan, D., & Weinberg, R. A. (2011). Hallmarks of cancer: the next generation. Cell, 144(5), 646-674.
  2. Vogelstein, B., & Kinzler, K. W. (2014). Cancer genes and the pathways they control. Nature Medicine, 10(8), 789-799.
  3. Garraway, L. A., & Lander, E. S. (2013). Lessons from the cancer genome. Cell, 153(1), 17-37.
  4. Schreiber, R. D., Old, L. J., & Smyth, M. J. (2011). Cancer immunoediting: integrating immunity's roles in cancer suppression and promotion. Science, 331(6024), 1565-1570.
  5. Hodi, F. S., et al. (2010). Improved survival with ipilimumab in patients with metastatic melanoma. New England Journal of Medicine, 363(8), 711-723.
  6. Topalian, S. L., et al. (2012). Safety, activity, and immune correlates of anti-PD-1 antibody in cancer. New England Journal of Medicine, 366(26), 2443-2454.
  7. June, C. H., et al. (2018). CAR T cell immunotherapy for human cancer. Science, 359(6382), 1361-1365.
  8. Sharma, P., & Allison, J. P. (2015). The future of immune checkpoint therapy. Science, 348(6230), 56-61.